Klobucher, Paulsen caution FDA on changing 510(K) system

Who says Republicans and Democrats can't agree on anything? Sen. Amy Klobuchar and Rep. Erik Paulsen, both of Minnesota, are cautioning the FDA against making changes to its product approval process that could threaten the medical device industry's position as a key source of U.S. exports. A key reason for the bipartisan cooperation: Minnesota boasts more than 400 medical device companies that together employ more than 50,000. Report

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.